# Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus

> **NCT02444364** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Missouri-Columbia**

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT02444364
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding withdrawn; no participants enrolled.
- **Last updated:** 2017-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02444364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02444364, "Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02444364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*